JP- and EP-Compliant Analysis of Impurities of COVID-19 Drug Dexamethasone

C10G-E096 Solutions for Infectious Diseases Infectious Diseases Infectious diseases are disorders caused by harmful microorganisms (pathogens) such as viruses, bacteria, fungi or parasites. The number of cases for these in the U.S. is led by bacteria with viruses a distant…

LAAN-A-LC-E298 Application News Analysis of Irbesartan Using an Integrated LC System - NexeraTM-i MT Y. Osaka „ System Suitability Test Table 1 shows the analytical conditions used for a system suitability test in the quantitative determination of irbesartan and amlodipine…

ERAS-1000-0167A LC Reversed-phase Shim-pack Series Shim-packTM VP-phenyl JP-Compliant Analysis of Impurities of COVID-19 Drug Dexamethasone 167A Keywords: the item of Purity (2) Related compounds of the JP(Japanese Pharmacopoeia) 20.0 mAU Peak 1. Dexamethasone 17.5 1. Dexamethasone (5.94 mg/L) : Dexamethasone…

LAAN-A-LC-E315 Application News No. High Performance Liquid Chromatography High-Speed Analysis of Linezolid following the Draft Guidance of International Harmonization of Pharmacopoeias L542 Linezolid is a new class of synthetic antibiotic with an oxazolidinone skeleton (Fig. 1). It was approved as…